January 26, 2023
Citybizlist
Lannett Announces 1 for 4 Reverse Stock Split
Lannett Company, Inc. (NYSE: LCI) today announced that its Board of Directors approved a 1-for-4 reve... See more »
Salix Pharmaceuticals: Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Launching in December for Constipation Awareness Month, Initiatives Include Partnerships with Well-Known Lifestyle and Health Care Practitioner InfluencersCampaign Coincides with Salix's Continued ...
Read full article »
January 26, 2023
MarketScreener
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
(marketscreener.com) Bristol Myers Squibb today announced topline results from TRANSCEND CLL 004, a P... See more »
January 26, 2023
Citybizlist
Lannett Announces 1 for 4 Reverse Stock Split
Lannett Company, Inc. (NYSE: LCI) today announced that its Board of Directors approved a 1-for-4 reve... See more »
January 26, 2023
MarketScreener
Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi (lisocabtagene maraleucel) Met Primary Endpoint of Complete Response Rate in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
(marketscreener.com) Bristol Myers Squibb today announced topline results from TRANSCEND CLL 004, a P... See more »
President
Robert Spurr
Salix Pharmaceuticals develops drugs and medical devices that prevents and treats various gastrointestinal disorders.
Read more